# The Conscious Fund

The Conscious Fund is a Venture Capital based in Lewes, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Lewes, United States
- **Region:** North America
- **Address:** Lewes, DE, United States
- **Founded:** 2018
- **Assets under management:** Undisclosed
- **Website:** theconscious.fund
- **LinkedIn:** https://www.linkedin.com/company/the-conscious-fund

## Regulatory record

- **Reports private funds:** No

## About

Backing the pioneers of psychedelic medicine, state of mind, and advanced therapeutics.

## Sectors

- Psychedelic Medicine
- Mental Health & Wellness
- Digital Health

## Offices

- Toronto, Canada

## People

- Henri Sant-Cassia — Co-Founder & Managing Partner
- Matt Schmidt — Co-Founder & Managing Partner

## Questions

### How is The Conscious Fund different from generalist healthcare VCs in the psychedelic space?

The fund's entire capital and diligence apparatus is built around the specific regulatory, clinical, and intellectual-property dynamics of psychedelic medicine — a depth of focus that generalist healthcare VCs do not replicate. This gives the firm an edge in deal sourcing and technical diligence for Schedule I drug-development programs, where domain networks matter. The trade-off is portfolio concentration in a single regulatory-risk category.

### What is the firm's geographic deployment focus?

North America and Europe are the primary deployment regions, reflecting the jurisdictions where psychedelic medicine regulatory reform has advanced farthest. The firm also selectively evaluates opportunities in the UK and Australia, where clinical-trial infrastructure and regulatory frameworks for psychedelic-assisted therapy are evolving.

### Who leads investment decisions at The Conscious Fund?

Co-founders Henri Sant-Cassia and Matt Schmidt lead the fund as managing partners, jointly responsible for investment decisions. Sant-Cassia's background includes cannabis-sector and early-stage venture investing; Schmidt's prior experience spans operations and capital markets. The firm has not publicly disclosed a formal investment committee beyond the two partners.

### Does The Conscious Fund invest in companies that handle scheduled substances?

Yes — the fund's thesis explicitly encompasses companies working with Schedule I compounds such as psilocybin and MDMA, which are being developed under FDA-authorized clinical trial frameworks and Breakthrough Therapy designations. The firm acknowledges the binary regulatory risk inherent in this mandate and incorporates it into portfolio construction and LP communication.

## Related profiles

- [The Community Fund](https://altss.com/profile/the-community-fund)
- [The Continent Venture Partners](https://altss.com/profile/the-continent-venture-partners)

---

Last updated: 2026-07-08T23:36:46.792Z

Canonical page: https://altss.com/profile/the-conscious-fund

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology